Quick Takeaways
- David C. Hastings has 5 issuer positions tracked on this page.
- Estimated disclosed ownership value: $886,587.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of David C. Hastings
- Location
- Jersey City, NJ
- Summary
- The estimated net worth of David C. Hastings is at least $886,587 dollars as of 12 Jan 2026. David C. Hastings is the Chief Financial Officer of Arbutus Biopharma Corp and owns shares of Arbutus Biopharma Corp (ABUS) stock worth about $820.2K. David C. Hastings is the Director of SCYNEXIS INC and owns shares of SCYNEXIS INC (SCYX) stock worth about $66.4K.
- Signature
- /s/ Christopher Galletta, attorney-in-fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow David C. Hastings and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Arbutus Biopharma Corp ($820,172).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of David C. Hastings
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| ABUS | Arbutus Biopharma Corp | Chief Financial Officer | $820,172 | 14 Feb 2025 | ||
| SCYX | SCYNEXIS INC | Director | $66,415 | 26 Jun 2025 | ||
| ETTX | Entasis Therapeutics Holdings Inc. | Director | 07 Jul 2022 | |||
| TRVI | Trevi Therapeutics, Inc. | Chief Financial Officer | 08 Jan 2026 | |||
| VBLT | Vascular Biogenics Ltd. | Director | 01 Jan 2023 |
Insider Transactions Reported by David C. Hastings:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.